These findings indicate that Bit1 expression is selectively lost in invasive breast carcinomas, suggesting that loss of Bit1 may accompany the transition from DCIS to invasive carcinoma during the progression of breast cancer. Here, PTRH2 is linked to ductal breast carcinoma in situ.